Could ear nerve stimulation calm racing hearts in POTS?

NCT ID NCT03124355

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This pilot study investigates whether stimulating a nerve in the earlobe (vagal nerve stimulation), alone or combined with two medications (galantamine and pyridostigmine), can help control heart rate and reduce symptoms in women with Postural Tachycardia Syndrome (POTS). Participants undergo tilt-table tests while receiving different combinations of stimulation and drugs. The goal is to see if these approaches can improve how the autonomic nervous system manages heart rhythm during standing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcutaneous vagal nerve stimulation, galantamine, pyridostigmine
What this could lead to
If successful, this approach could point toward a non-drug or drug-combination therapy to help manage POTS symptoms and improve quality of life.
What could go wrong
This is a very small, early-phase pilot study with only 11 participants, so results may not apply broadly. The interventions may not produce meaningful benefits or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTURAL TACHYCARDIA SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.